Latest common stock for BIOSU: $140M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) (BIOSU) currently reports a common stock of $140M as of June 2023. That compares with $230M in the prior-year period — down 41.1% year over year. Use the charts on this page to explore BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s common stock history and peer comparisons.
BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s common stock decreased from $230M to $140M — a 41.1% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) reported $140M in common stock as of June 2023. That compares with $230M in the prior-year period — down 41.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War), and consider following BIOSU for alerts when major investors trade the stock.